US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 397.270
  • +0.630+0.16%
Close Dec 20 16:00 ET
  • 394.850
  • -2.420-0.61%
Post 20:01 ET
102.31BMarket Cap-209.09P/E (TTM)

About Vertex Pharmaceuticals Company

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Company Profile

SymbolVRTX
Company NameVertex Pharmaceuticals
Listing DateJul 4, 1991
Issue Price13.75
Founded1989
CEODr. Reshma Kewalramani, M.D.
MarketNASDAQ
Employees5400
Fiscal Year Ends12-31
Address50 Northern Avenue
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-617-341-6100
Websitehttp://www.vrtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Reshma Kewalramani, M.D.
  • Director, President and Chief Executive Officer
  • 20.59M
  • Dr. E Morrow Atkinson, III, PhD
  • Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations
  • --
  • Dr. Ourania Tatsis
  • Executive Vice President and Chief Regulatory and Quality Officer
  • --
  • Dr. David Altshuler
  • Executive Vice President, Global Research and Chief Scientific Officer
  • 6.54M
  • Charles F. Wagner, Jr
  • Executive Vice President and Chief Financial Officer
  • 7.37M
  • Stuart A. Arbuckle
  • Executive Vice President and Chief Operating Officer
  • 9.00M
  • Carmen Bozic
  • Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer
  • --
  • Jonathan Biller
  • Executive Vice President and Chief Legal Officer
  • --
  • Amit K. Sachdev, J.D.
  • Executive Vice President and Chief Patient and External Affairs Officer
  • --
  • Kristen Ambrose
  • Senior Vice President and Chief Accounting Officer
  • --
  • Dr. Jeffrey M Leiden, PhD
  • Executive Chairman of the Board
  • 6.60M
  • Michel Lagarde
  • Independent Director
  • 449.08K
  • Dr. Jennifer Schneider, M.D.
  • Independent Director
  • --
  • Nancy A. Thornberry
  • Independent Director
  • 407.65K
  • Diana L. McKenzie
  • Independent Director
  • 553.11K
  • Dr. Sangeeta N. Bhatia, PhD
  • Independent Director
  • 550.31K
  • Dr. Alan M. Garber, M.D.,PhD
  • Independent Director
  • 537.63K
  • Bruce I. Sachs
  • Lead Independent Director
  • 600.04K
  • Suketu Upadhyay
  • Independent Director
  • 544.66K
  • Lloyd A. Carney
  • Independent Director
  • 559.79K
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List

Investment Theme Gene Editing
Gene Editing
Intraday+0.52%